01 6OREXO US INC
01 610946010
01 6Blank
01 6Y
01 62032-09-18
Patent Expiration Date : 2032-09-18
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 10946010
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204242
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-09-18
Patent Expiration Date : 2032-09-18
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 10946010
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204242
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-09-18
Patent Expiration Date : 2032-09-18
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 10946010
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204242
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-09-18
Patent Expiration Date : 2032-09-18
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 10946010
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204242
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-09-18
Patent Expiration Date : 2032-09-18
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 10946010
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204242
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-09-18
Patent Expiration Date : 2032-09-18
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 10946010
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204242
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-09-18
